1. Lieberman JA (2007) Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care. Prim care companion. J Clin Psychiatry 9:25–31
2. NICE - National Institute for Clinical Excellence (2004) Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia. Technology Appraisal Guidance 77. NICE, London
3. Carson S, Yen PY, McDonagh MS (2006) Drug class review on newer sedative hypnotics. Final Report Update 1. Oregon Evidence-based Practise Center, http://ecfd.oregon.gov/DAS/OHPPR/HRC/docs/NSH_EPC.pdf (letzter Zugriff: 19.10.2007)
4. Dundar Y, Boland A, Strobl J et al (2004) Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation. Health Technol Assess 8:1–125
5. Madre LK, Califf RM, Reynolds RF et al (2006) Views from academia, industry and regulatory agencies. In: Strom BL, Kimmel SE (eds) Textbook of pharmacoepidemiology. Wiley, Chinester, pp 63–88